After false starts and incremental gains, scientists crack the problem that made breathing impossible. Will answers come fast ...
Modulator pills transformed cystic fibrosis care. But the fight for a cure is not over — so long as research remains funded.
I spent much of my childhood trying to hide my CF. But after an emergency double-lung transplant, the loss of my sister, and years of mental health challenges, I’m proud to belong to a CF community ...
Insmed's Brensocatib has received its first approval as a treatment for non cystic fibrosis bronchiectasis. The product ...
Executives from 4D Molecular Therapeutics (NASDAQ:FDMT) outlined the company’s gene therapy platform, clinical progress, and commercialization plans during a Barclays analyst discussion in Miami, ...
Haunted by the cystic fibrosis patients he could not help, one Iowa doctor commits his life to understanding what is broken deep inside their cells.
Salt rooms regenerate health skin cells and boost our breathing. Here's what to look for when finding a salt room experience.
Morning Overview on MSN
Study: Breath test could track antibiotic levels and treatment response
Researchers have shown that antibiotic concentrations can be detected and measured in the exhaled breath of patients receiving intravenous treatment, raising the possibility that a simple breath test ...
The pseudomonal infections clinical trial analysis report delivers important insights into ongoing research of 10+ pipeline ...
These companies have impressive track records of navigating the biggest challenges in their industry.
Phage-focused BiomX is undergoing a “strategic and financial reset” in efforts to improve its position, mapping out a possible shift from therapeutics to the defense sector. | Phage-focused BiomX is ...
Artisan Partners, an investment management company, released its fourth-quarter 2025 investor letter for “Artisan Small Cap ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results